1. Holmberg L, Anderson H. (2004) HABITS hormonal replacement therapy after breast cancer - is it safe? The Lancet, 2004; 363: 453-455

2. Chlebowski RW. Menopausal hormone therapy after breast cancer. The Lancet, 2004; 363: 410-411

3. Loprinzi CL et al (1994) Megesterol acetate for the prevention of hot flashes. N Engl J Med, 331, 347-352

4. Plumb, JM and Guest, JF (2000) Economic impact of tibolone compared with continuous-combined HRT in the management of post-menopausal women with climacteric symptoms in the UK. Pharmacoeconomics. 18. 477−86

5. Valdivia I, Ortega D. (2000) Mammographic density in postmenopausal women treated with tibolone, estriol or conventional hormone replacement therapy. Clin Drug Invest. 20:101-719.

6. Million Women Study collaborators (2003) Breast cancer and hormone-replacement therapy in the Million Women study. The Lancet 362. 419 – 427.

7. PJB Publications Ltd (2003) Tibolone to be studied in breast cancer patients. Scrip. 2856, 21.

8. Loprinzi CL. et al. (2000). Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. The Lancet. 356, 2059-2063.

9. Kishan J et al (2000) Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: A University of Rochester cancer Center Community Clinical Oncology Program Study.

10. Germaine LM and Freedman RR (1984) Behavioural treatment of menopausal hot flashes: evaluation by objective methods. Journal of Consulting and Clinical Psychology, 52, 1072-1079

11. Freedman RR and Woodward S (1992) Behavioural treatment of menopausal hot flashes: evaluation by ambulatory monitoring. American Journal of Obstetrics and Gynaecology, 167, 436 – 439

12. Irvine JH et al (1996) The effects of relaxation response training on menopausal symptoms. Journal of psychosomatic Obstetrics and Gynaecology, 17, 202-207

13. Wijma AG et al (1997) Treatment of menopausal symptoms with applied relaxation: a pilot study. Journal of Behaviour Therapy and Experimental Psychiatry, 28, 251-261

14. Tukmachi E (2000) Treatment of hot flushes in breast cancer patients with acupuncture. Acupuncture in medicine, 18, 22-27

15. Hammar M et al (1999) Acupuncture treatment of vasomotor symptoms in men with prostate carcinoma: a pilot study. Journal of Urology, 161, 853-856

16. Mahady GB, Fabricant D, Chadwick LR, Dietz B (2002) Black cohosh: an alternative therapy for menopause? Nutrition in Clinical Care 5, 283-9

16. Jacobsen JS, Troxel AB, Evans J, et al. (2001) Randomised trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. Journal of Clinical Oncology, 19, 2739-2745.

17. National centre for complementary and alternative medicine (2004) Questions and answers about black cohosh and the symptoms of menopause. (Available at http://ods.od.nih.gov/factsheets/blackcohosh.html#a2) Accessed November 2004.

18. Lupu R Et al (2003) Black cohosh, a menopausal remedy, does not have estrogenic activity and does not promote breast cancer cell growth. International Journal Oncology, 23, 1407-1412.

19. The Medicines and Healthcare products Regulatory Agency (2004) Black cohosh (Available at http://medicines.mhra.gov.uk/ourwork/licensingmeds/herbalmeds/herbalsafety.htm#black) Accessed November 2004.

20. Hansen LB (2003) What non-hormonal therapies are effective for postmenopausal vasomotor symptoms? The journal of family practice, 52, 4

21. Quella SK, Loprinzi CL, Barton DL, et al (2000) Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. Journal of Clinical Oncology, 18, 1068-74

22. National centre for complementary and alternative medicine (2004) Soy: Health claims for soy protein, questions about other components. (Available at http://www.cfsan.fda.gov/~dms/fdsoypr.html ) Accessed November 2004.

23. Hoda D, Perez DG, Loprinzi CL (2003) Hot flashes in breast cancer survivors. The Breast Journal, 9, 431-438.

24. Baber RJ, Templeman C, Morton T et al (1999) Randomised placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric, 2, 85-92.

25. Knight DC, Howes JB, Eden JA (1999) The effect of Promensil, an isoflavone extract on menopausal symptoms. Climacteric, 2, 79-84.

26. Huntley AL, Ernst E (2003) A systematic review of herbal medicinal products for the treatment of menopausal symptoms. Menopause, 10, 465-76

27. Jeri AR (2002) The use of an isoflavone supplement to relieve hot flushes. The female patient, 27, 35-37.

28. Hunter MS and Liao KLM (1996) An evaluation of a four-session cognitive behavioural intervention for menopausal hot flushes. British Journal of Health Psychology, 1, 113-125.

29. Hunter M (2003) Cognitive behavioural interventions for premenstrual and menopausal symptoms. Journal of Reproductive and Infant Psychology, 21, 183-193.

30. Barton et al (1998) Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. Journal of Clinical Oncology, 16, 495-500

31. Barton DL, Loprinzi CL, Quella SK, et al (1998) Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. Journal of Clinical Oncology, 16, 495-500.

32. Chenoy R, Hussain S, Tayob Y, et al (1994) Effect of oral gamolenic acid from evening primrose on menopausal flushing. BMJ, 308, 501-503.

33. Younus J, Simpson I, Collins A, et al (2003) Mind control of menopause. Women's health issues, 13, 74-78

34. Shanafelt TD, Barton DL, Adjei AA, Loprinzi CL (2000) Pathophysiology and treatment of hot flashes. Mayo clinic proc, 77, 1207-18.

35. National Osteoporosis Society (2004). Calcium rich foods and bone health factsheet. (Available at www.nos.org.uk/InfoSheets/CALCIUM.doc ) Accessed Jan 2004

36. Going S et al (2003) Effects of exercise on bone mineral density in calcium-replete postmenopausal women with and without hormone replacement therapy. Osteoporosis Int, 14. 637-43.

37. Sharpe M, Noble S and Spencer CM (1999) Alendronate: an update of its use in osteoporosis. Drugs. 61: 999-1039

38. Harris ST et al (1999) Effects of risedronate treatment on vertebral and non-vertebral fractures in women with postmenopausal osteoporosis. A randomised controlled trial. JAMA. 282. 1344−52

39. Cranny, A et al (2001) A meta-analysis of etidronate for the treatment of post-menopausal osteoporosis. Osteoporosis Int. 12. 140−51

40. Delmas et al (1997) Effects of raloxifene on bone mineral density, serum cholesterol and endometrial proliferation. In post-menopausal women. New. Engl.J Med. 337. 1641−7.

41. Cummings et al (1998) Raloxifene reduces the risk of breast cancer and may decrease endometrial cancer in post-menopausal women. Two-year findings of the MORE trial. Proc. ASCO. 17. 2a Abs 3.